Showing results (31-40 of 648) with videos related to

Sort By:
Pageof 65
International Journal of Cancer|February 27, 1999
CD3xCD19 bispecific antibodies and CD28 bivalent antibodies enhance T-cell reactivity against autologous leukemic cells in pediatric B-ALL bone marrowO Manzke, F Berthold, K Huebel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 25, 2000
Is the international prognostic score for advanced stage Hodgkin's disease applicable to early stage patients? German Hodgkin Lymphoma Study GroupJ Franklin, U Paulus, D Lieberz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1992
Activation of cytokines in Hodgkin's diseaseH Tesch, A C Feller, M Jücker, et al.
Medizinische Klinik (Munich, Germany : 1983)|October 18, 2001
[Factitious disorders. Hematologic, neurologic and dermatologic symptoms in a physician with factitious disorder]M R Weihrauch, K Rabe, M Kochanek, et al.
British Journal of Haematology|May 31, 2001
Class switch recombination was specifically targeted to immunoglobulin (Ig)G4 or IgA in Hodgkin's disease-derived cell linesJ Irsch, J Wolf, H Tesch, et al.
Studies in Health Technology and Informatics|February 24, 2001
Can factors influencing in-patient treatment in Hodgkin's disease be identified?--Retrospective analysis of HD6 patients of the GHSGB Pfistner, U Paulus, J P Glossmann, et al.
Leukemia|January 22, 1998
A phase I/II study of idarubicin, dexamethasone and interferon-alpha (I-Dexa) in patients with relapsed or refractory multiple myelomaK Hübel, H Tesch, B Kröger, et al.
British Journal of Haematology|August 25, 1999
Detection of a Hodgkin/Reed-Sternberg cell specific immunoglobulin gene rearrangement in the serum DNA of a patient with Hodgkin's diseaseM Kornacker, A Jox, M Vockerodt, et al.
Bone Marrow Transplantation|March 20, 1999
Progressive multifocal leukoencephalopathy after autologous bone marrow transplantation and alpha-interferon immunotherapyD Re, S Bamborschke, W Feiden, et al.
Annals of Hematology|March 23, 2001
Immunomagnetic enrichment of CD138 positive cells from weakly infiltrated myeloma patients samples enables the determination of the tumor clone specific IgH rearrangementA Draube, R Pfister, M Vockerodt, et al.
Pageof 65